Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2023 - 01 - 09 crawled time : 14:00 save search
Novocure Announces Preliminary Full Year and Fourth Quarter 2022 Net Revenues and Provides Company Update
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
NVCR | $12.04 -3.37% -3.49% 1.4M
|
Health Technology
|
| O: -5.85%
H: 1.0%
C: -11.11%
year update
Schrödinger Provides Update on Progress Across the Business and Outlines 2023 Company Strategic Priorities
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.29%
H: 0.27%
C: -3.89%
SDGR | $25.04 1.13% 1.12% 490K
|
Technology Services
|
| O: 2.1%
H: 1.62%
C: 1.03%
update
AlloVir Announces Plans to Complete Enrollment in Three Phase 3 Posoleucel Studies in 2023
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
ALVR | $0.7521 2.34% 2.29% 570K
|
Health Technology
|
| O: 0.97%
H: 2.61%
C: -2.12%
Monte Rosa Therapeutics Outlines Progress Across Portfolio of Molecular Glue Degraders and Key Anticipated Milestones for 2023
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
GLUE | $5.8 -4.29% -4.48% 110K
|
Professional, Scientific, and T...
|
| O: 1.26%
H: 0.0%
C: -15.38%
rosa therapeutics molecular
Moderna Announces Advances Across mRNA Pipeline and Provides Business Update
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
MRNA | News S | $103.45 -0.33% -0.33% 2M
|
Health Technology
|
| O: 0.8%
H: 3.61%
C: 1.18%
mrna update
CureVac Appoints Alexander Zehnder as CEO From April 1, 2023
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
CVAC | $2.57 -3.57% -3.7% 920K
|
Health Technology
|
| O: 22.46%
H: 10.13%
C: 2.42%
ceo
Syros Announces Clinical Updates and 2023 Strategic Priorities
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
SYRS | $5.105 -8.18% -8.91% 130K
|
Health Technology
|
| O: 1.12%
H: 1.11%
C: -2.78%
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2022
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
BFRI | $1.8 -1.02% -1.03% 76K
|
|
| O: 2.2%
H: 21.73%
C: 9.81%
year
2seventy bio Provides Company Outlook for 2023
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
TSVT | $5.06 4.12% 3.95% 900K
|
|
| O: 2.8%
H: 4.67%
C: 0.49%
Kintara Therapeutics to Present at the Biotech Showcase Conference on January 10, 2023
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
KTRA | $0.1038 -3.08% -3.18% 1.8M
|
Distribution Services
|
| O: -2.94%
H: 7.77%
C: 0.0%
conference biotech therapeutics
STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
STAA | $46.29 -0.71% -0.71% 330K
|
Health Technology
|
| O: -5.07%
H: 18.1%
C: 14.82%
sales
Dexcom Appoints Teri Lawver as Chief Commercial Officer
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.53%
H: 0.26%
C: -2.07%
DXCM | $133.83 -1.97% -2.01% 3.2M
|
Health Technology
|
| O: -2.9%
H: 1.09%
C: -2.13%
commercial
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
DXCM | $133.83 -1.97% -2.01% 3.2M
|
Health Technology
|
| O: -2.9%
H: 1.09%
C: -2.13%
year
Bright Minds Biosciences Announces Resignation of Board Member
Published: 2023-01-09 (Crawled : 14:00) - brightmindsbio.com
DRUG | $1.25 -6.61% 11K
|
Manufacturing
|
| O: -2.98%
H: 1.89%
C: -4.62%
Bausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
BLCO 4 | $14.31 1.71% 0.0% 340K
|
n/a
|
| O: 0.56%
H: 0.99%
C: -0.37%
conference presentation update
Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
BLCO 4 | $14.31 1.71% 0.0% 340K
|
n/a
|
| O: 0.56%
H: 0.99%
C: -0.37%
preservision
Precision BioSciences Recaps 2022 Accomplishments and Outlines 2023 Corporate Priorities and Planned Portfolio Milestones
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
DTIL | $11.5 -10.65% -11.91% 220K
|
Health Technology
|
| O: 0.74%
H: 1.46%
C: -8.76%
Smart Railways Market worth $43.0 billion by 2027 - Exclusive Report by MarketsandMarkets™
Published: 2023-01-09 (Crawled : 14:00) - prnewswire.com
ALSMY | $1.46 -1.78% 900K
|
Manufacturing
|
| O: 0.0%
H: 0.38%
C: -1.15%
report smart market
Xtant Medical Appoints Mark Schallenberger as Chief Operations Officer
Published: 2023-01-09 (Crawled : 14:00) - xtantmedical.com
XTNT | $0.7844 -0.62% 0.0% 180K
|
Health Technology
|
| O: -9.52%
H: 10.61%
C: 6.32%
medical
Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
ALPMF | News | $9.594 43.47% 2.2K
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
ALPMY | News | $9.34 -1.11% 690K
|
Manufacturing
|
| O: 0.58%
H: 0.44%
C: -0.31%
SELB M | $0.8812 -8.0% 2.12% 0
|
Health Technology
|
| O: 9.76%
H: 5.93%
C: -1.48%
agreement
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.